TickerFacts.

Sonoma Pharmaceuticals, Inc. (SNOA): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2016-03-31, 2020-03-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$2.32M
Year ended 2026-03-31
2011-03-31: -$7.11M2012-03-31: -$6.14M2013-03-31: -$3.11M2014-03-31: -$5.77M2015-03-31: -$6.41M2016-03-31: -$14.47M2017-03-31: -$12.73M2018-03-31: -$13.70M2019-03-31: -$10.80M2020-03-31: -$7.08M2021-03-31: -$3.22M2022-03-31: -$5.70M2023-03-31: -$4.45M2024-03-31: -$4.53M2025-03-31: -$3.57M2026-03-31: -$2.32M-$2.32M
2011-03-31 EBITDA (USD) 2026-03-31
Period endedEBITDAChange YoYSource filing
2026-03-31-$2.32Mn/m2026-06-16, From 2025-04-01
2025-03-31-$3.57Mn/m2026-06-16, From 2024-04-01
2024-03-31-$4.53Mn/m2025-06-17, From 2023-04-01
2023-03-31-$4.45Mn/m2024-06-17, From 2022-04-01
2022-03-31-$5.70Mn/m2023-06-21, From 2021-04-01
2021-03-31-$3.22Mn/m2022-07-13, From 2020-04-01
2020-03-31-$7.08Mn/c2021-07-14, From 2019-04-01
2019-03-31-$10.80Mn/m2020-07-10, From 2018-04-01
2018-03-31-$13.70Mn/m2019-07-01, From 2017-04-01
2017-03-31-$12.73Mn/m2018-06-26, From 2016-04-01
2016-03-31-$14.47Mn/c2017-06-28, From 2015-04-01
2015-03-31-$6.41Mn/m2016-06-21, From 2014-04-01
2014-03-31-$5.77Mn/m2015-06-16, From 2013-04-01
2013-03-31-$3.11Mn/m2014-06-30, From 2012-04-01
2012-03-31-$6.14Mn/m2013-06-25, From 2011-04-01
2011-03-31-$7.11Mn/a2012-06-21, From 2010-04-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31-$2.32Mn/m
Nephros Inc (NEPH)2025-12-31$1.29M+812.1%
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$18.59Mn/m
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31-$24.53Mn/m
Allurion Technologies, Inc. (ALUR)2025-12-31-$29.17Mn/m
Sensus Healthcare, Inc. (SRTS)2025-12-31-$9.91Mn/m
Premier Air Charter Holdings Inc. (PREM)2025-12-31-$1.95Mn/m
Nexgel, Inc. (NXGL)2025-12-31-$2.90Mn/m
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31-$51.48Mn/m

Compare SNOA, NEPH, VVOS, BDMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗